ArticleClinical drug investigation2026

Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18-64 Years in Hong Kong: A Population-Based Cohort Study.

George N Okoli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.